Clinical Trial Update: Efficacy and Safety of Neoadjuvant Envafolimab Combined With Albumin-bound Paclitaxel and Carboplatin for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating neoadjuvant envafolimab in combination with albumin-bound paclitaxel and carboplatin for resectable locally advanced esophageal squam…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• CARBOPLATIN (Carboplatin)
• Envafolimab (envafolimab)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Esophageal Squamous Cell Carcinoma, Neoadjuvant Therapy | Phase 2 | Status: RECRUITING